SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-059093
Filing Date
2020-05-11
Accepted
2020-05-11 07:08:34
Documents
3
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2014909-6_8k.htm 8-K 19149
2 EXHIBIT 99.1 tm2014909d6_ex99-1.htm EX-99.1 100732
3 GRAPHIC tm2014909d6_ex99-1img01.jpg GRAPHIC 7958
  Complete submission text file 0001104659-20-059093.txt   132318
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 20862567
SIC: 2834 Pharmaceutical Preparations